Hepatitis

TAI Briefing: An Update on Hepatitis C in the United States

 

The AIDS Institute invites you to a briefing:

An Update on Hepatitis C in the United States

Tuesday, August 2, 2016

The AIDS Institute urges Congress to support HIV & Hepatitis testing programs in final opioid legislation (H.R. 5046/S. 524)

Below are letters to the House and Senate urging support for HIV and hepatitis testing programs in the final opioid legislation. 

TAI comments on the Pharmaceutical & Therapeutics Committee review of hepatitis C medications

Below are The AIDS Institute's comments on the Florida Medicaid Pharmaceutical & Therapeutics Committee review of hepatitis C medications. 

Update: Hepatitis C Testing Coverage Guide 2016

Below you will find The AIDS Institute's updated Hepatitis C Testing Coverage Guide for 2016, as well as our press release for Hepatitis Testing Day. 

National Academy Report Concludes Hepatitis C Can Be Eliminated in the U.S.

Washington, DC– “We applaud the National Academy of Sciences for releasing its report, “Eliminating the Public Health Problem of Hepatitis B and C in the United States, which concludes elimination of hepatitis C as a public health problem in the United States is feasible and can be achieved with the right resources, commitment, and strategy,” said Carl Schmid, Deputy Executive Directo

Coverage of Hepatitis B & C Drugs - Florida 2015 Silver Qualified Health Plans

Tampa, FL – Eight out of the 12 major insurers offering qualified health plans in Florida charge beneficiaries coinsurance as high as 30 to 50 percent of cost for all or almost all hepatitis B and C drugs. This makes access to these medications difficult for people living with hepatitis.

Update: Hepatitis C Testing Coverage Guide

May 19, 2015 - The AIDS Institute's HCV Testing Coverage Guide has been updated for 2015. Click here to view the guide, or click below. 

August 2014 Update: The AIDS Institute Releases Hepatitis C Testing Coverage Guide in Observance of Hepatitis Testing Day

May 19, 2014 

“This coverage guide is a useful tool for understanding how the recently revised recommendations by the USPSTF on hepatitis C screening will impact coverage by Medicaid, Medicare and private insurance as a result of the ACA."

Syndicate content